Cambridge Enterprise, University of Cambridge
Cambridge Enterprise exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.
|Telephone:||+44 (0)1223 760 339|
|Address:||Hauser Forum, 3 Charles Babbage Road, Cambridge|
Cambridge Enterprise offers support to all of the University’s research fields, from science, technology, engineering, maths and medicine to the arts, humanities and social sciences. It is through us that many of the University’s inventions and ideas are protected, licences and consultancy contracts are negotiated, and funding is acquired by start-ups and spin-outs.
Aurelius Environmental, part of Aurelius Holdings, and Dr Vasant Kumar from the University of Cambridge Department of Materials Science and Metallurgy, have won a grant worth over 1.3 million Euros to develop a novel hydrometallurgical process.
29 August 2017Read in full
Cambridge Enterprise, the commercialisation arm of the University of Cambridge, and specialist growth factor manufacturer Qkine Ltd have signed a key licensing deal for Activin A production technology.
7 August 2017Read in full
Evotec AG announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas. The focus will be on a range of newly discovered RNA modulating enzyme targets.
28 July 2017Read in full
Sphere Fluidics Limited and its partners have just won a £1 million grant to develop a novel automated single cell genome engineering platform.
17 July 2017Read in full
Tony Raven, CEO of Cambridge Enterprise at the University of Cambridge, has been awarded the Lifetime Achievement Award by Global University Venturing (GUV).
25 May 2017Read in full
Improbable, founded by Cambridge alumni Herman Narula (Girton 2007) and Rob Whitehead (Robinson 2009), just became the UK's latest $1billion tech start-up.
16 May 2017Read in full
Z Factor Limited announced that it has completed a £7 million Series A investment led by existing investor Medicxi. Cambridge Enterprise & Cambridge Innovation Capital have also joined in the founding round.
4 May 2017Read in full
Last week, the House of Commons Science and Technology Committee, released findings from its inquiry ‘Managing intellectual property and technology transfer’.
24 March 2017Read in full
Cambridge Enterprise has joined in a £14 million Series A funding round into ApcinteX Limited, a University of Cambridge spin-out company developing a new therapy for haemophilia.
3 February 2017Read in full
A majority stake in Cambridge Graphene Ltd., a spin-out company from the University of Cambridge, has been acquired by Versarien plc.
23 January 2017Read in full
Investment Director / Investment Manager (Life Science)
Join us in helping to build and fund some of the most exciting life science technology companies of tomorrow Sitting at the h...
Purchase Ledger Administrator
Sitting at the heart of Europe’s most successful technology cluster, Cambridge Enterprise is the commercialisation arm of the Un...
Salary: £20,000 - £30,000